Literature DB >> 12488670

Ecthyma gangrenosum: considerations in a previously healthy child.

Arezoo Zomorrodi1, Ellen R Wald.   

Abstract

Ecthymagangrenosum is a skin lesion that is most commonly caused by. Although ecthyma gangrenosum usually develops in patients with underlying immunodeficiencies or chronic diseases, there have been reports of its appearance in previously healthy children. A review of such patients in the English literature showed that most of them had either previously undetected immunodeficiencies or transient risk factors that predisposed them to the development of ecthyma gangrenosum. We report a patient without apparent antecedent predisposing risk factors for ecthyma gangrenosum who developed chronic neutropenia 1 week after presentation. It is important for the primary care provider to recognize ecthyma gangrenosum, treat it with appropriate antimicrobial agents and investigate the patient for occult immunodeficiencies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12488670     DOI: 10.1097/00006454-200212000-00016

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  19 in total

1.  Pseudomonas aeruginosa sepsis and ecthyma gangrenosum as initial manifestations of primary immunodeficiency.

Authors:  María Baro; Miguel Angel Marín; Jesús Ruiz-Contreras; Sira Fernandez de Miguel; Ignacio Sánchez-Díaz
Journal:  Eur J Pediatr       Date:  2003-12-20       Impact factor: 3.183

2.  Imaging findings of ecthyma gangrenosum, an unusual complication of pseudomonas sepsis.

Authors:  Jane S Kim; Rosanna Ricafort; Evan S Garfein; Terry L Levin
Journal:  HSS J       Date:  2011-08-20

3.  Ecthyma Gangrenosum: A Rare Cutaneous Manifestation Caused by Stenotrophomonas maltophilia in a Leukemic Patient.

Authors:  Young Min Son; So Young Na; Hye Young Lee; Jin Ok Baek; Jong Rok Lee; Joo Young Roh
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

4.  Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection.

Authors:  Bryan J Berube; Katherine R Murphy; Matthew C Torhan; Nicholas O Bowlin; John D Williams; Terry L Bowlin; Donald T Moir; Alan R Hauser
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

Review 5.  Ecthyma gangrenosum and ecthyma-like lesions: review article.

Authors:  M Vaiman; T Lazarovitch; L Heller; G Lotan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-19       Impact factor: 3.267

6.  Ecthyma gangrenosum in a previously healthy infant.

Authors:  Su Han Koo; Joon Ho Lee; Heakyeong Shin; Jong Im Lee
Journal:  Arch Plast Surg       Date:  2012-11-14

7.  Surgical strategies in the management of ecthyma gangrenosum in paediatric oncology patients.

Authors:  B A Khalil; C T Baillie; S E Kenny; G L Lamont; R R Turnock; B L Pizer; H F K van Saene; P D Losty
Journal:  Pediatr Surg Int       Date:  2008-04-22       Impact factor: 1.827

8.  Ecthyma gangrenosum of the scrotum: a case report.

Authors:  Wei Phin Tan; Benjamin A Sherer; Jerome Hoeksema
Journal:  Front Med       Date:  2016-03-03       Impact factor: 4.592

9.  Ecthyma gangrenosum of a single limb.

Authors:  George M Varghese; Pushpa Eapen; Susanne Abraham
Journal:  Indian J Crit Care Med       Date:  2011-07

10.  Ecthyma gangrenosum in a previously healthy pediatric patient and associated facial paralysis and persistent hyperplastic primary vitreous.

Authors:  Ibrahim Hakan Bucak; Gökhan Tümgör; Eda Mengen; Fatih Temiz; Mehmet Turgut
Journal:  Am J Case Rep       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.